Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China · Delayed Price · Currency is CNY 12.38
+0.29 (2.40%)
Jun 23, 2026, 3:00 PM CST
SHA:688526 Market Cap
SHA:688526 has a market cap or net worth of 5.61 billion as of June 23, 2026. Its market cap has decreased by -28.42% in one year.
Market Cap
5.61B
Enterprise Value
3.02B
Revenue
932.09M
Ranking
n/a
PE Ratio
14.40
Stock Price
12.38
Market Cap Chart
Since September 22, 2020, SHA:688526's market cap has decreased from 14.68B to 5.61B, a decrease of -61.81%. That is a compound annual growth rate of -15.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 5.61B | -20.77% |
| Dec 31, 2025 | 7.08B | 6.68% |
| Dec 31, 2024 | 6.64B | -30.15% |
| Dec 29, 2023 | 9.50B | -9.03% |
| Dec 30, 2022 | 10.44B | -18.45% |
| Dec 31, 2021 | 12.81B | -33.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xiangxue Pharmaceutical | 6.55B |
| Chengdu Kanghua Biological Products | 6.02B |
| Youcare Pharmaceutical Group | 5.86B |
| Suzhou Fengbei Biotech Stock | 5.77B |
| Hangzhou Biotest Biotech | 5.59B |
| Shanghai OPM Biosciences | 5.30B |
| Jiangsu Aidea Pharmaceutical Group | 5.29B |
| Anhui Huaheng Biotechnology | 5.20B |